SIC: 2835 - IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
State location: TX | State of Inc.: DE | Fiscal Year End: 1231
formerly: CIPHERGEN BIOSYSTEMS INC (filings through 2007-08-17)
formerly: VERMILLION, INC. (filings through 2020-06-10)
(CF Office: 03 Life Sciences)
Get insider transactions for this issuer.
File Number: 333-221092
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 424B5 | Documents | Prospectus [Rule 424(b)(5)] Acc-no: 0001193125-19-183082 (33 Act) Size: 397 KB |
2019-06-27 | 333-221092 19922822 |
| 424B5 | Documents | Prospectus [Rule 424(b)(5)] Acc-no: 0001193125-19-181334 (33 Act) Size: 401 KB |
2019-06-25 | 333-221092 19919412 |
| 424B5 | Documents | Prospectus [Rule 424(b)(5)] Acc-no: 0000926617-18-000024 (33 Act) Size: 595 KB |
2018-04-17 | 333-221092 18757454 |
| 424B5 | Documents | Prospectus [Rule 424(b)(5)] Acc-no: 0000926617-18-000023 (33 Act) Size: 570 KB |
2018-04-16 | 333-221092 18757449 |
| 424B5 | Documents | Prospectus [Rule 424(b)(5)] Acc-no: 0000926617-18-000017 (33 Act) Size: 582 KB |
2018-04-12 | 333-221092 18752595 |
| 424B5 | Documents | Prospectus [Rule 424(b)(5)] Acc-no: 0000926617-18-000015 (33 Act) Size: 566 KB |
2018-04-12 | 333-221092 18752571 |
| EFFECT | Documents | Notice of Effectiveness Acc-no: 9999999995-17-002903 (33 Act) Size: 1 KB |
2017-11-07 17:00:00 | 333-221092 171184939 |
| S-3 | Documents | Registration statement under Securities Act of 1933 Acc-no: 0000926617-17-000053 (33 Act) Size: 1 MB |
2017-10-24 | 333-221092 171151571 |